0 followers
Urovant Sciences, innovations in urology. Our lead therapeutic candidate is vibegron (RVT-901), an investigational oral β3-adrenergic agonist
Industries
Headquarters
Employees
Links
James Robinson
Elicio Therapeutics
1 follower
Cellares
2 followers
PostEra
2 followers
Thermo Fisher Scientific
143 followers
Genentech
144 followers
Gilead Sciences
121 followers
Regeneron
89 followers
Agilent Technologies
61 followers
Alexion Pharmaceuticals
32 followers
GRAIL
27 followers
Kura Oncology
17 followers
Discover companies